|The SD IpaA ipaa (Catalog #MBS415034) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s SD IpaA can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB-Re).
WB: 1:1000 analysis of recombinant protein SD IpaA with Anti-SD IpaA. Researchers should empirically determine the suitability of the SD IpaA ipaa for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The SD IpaA ipaa product has the following accession number(s) (GI #81243967) (NCBI Accession #ABB64676). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Anti-SD IpaA Antibody with the following immunoassay(s):
Raised In: Purified mouse monoclonal antibody generated using E.coli expressed recombinant protein Shigella dysenteriae IpaA as immunogen.
Storage Buffer: citrate-tris-HCl buffer pH7.0 with 0.02% Proclin 300. Immunogen: Recombinant protein corresponding to fragment (aa/240-581) SD IpaA. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SD IpaA are readily searchable from our website. Different antibodies against the same target such as SD IpaA may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.